Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPN-305 for Delayed Graft Function in Renal Transplant
NCT01794663Phase 2Completed
- Sponsor
- Opsona Therapeutics
- Start
- Oct 2012
- Primary completion
- Jun 2016
- Modality
- Monoclonal Antibodies
- Countries
- 11
01
Overview
Phase 2, randomised, double-blind trial in delayed graft function (DGF) comparing OPN-305 with Placebo (2 arms). Primary endpoint: Measure of Early Graft Function (EGF) at 7 days. Started Oct 2012; status: completed.
02
Drugs
tomaralimab
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT01794663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01794663.